Evidence map›Paper›PMID 23588498›Full record

ArticleJAMA neurology2013

C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex.

Beth A Dombroski, Douglas R Galasko, Ignacio F Mata, Cyrus P Zabetian, Ulla-Katrina Craig, Ralph M Garruto, Kiyomitsu Oyanagi, Gerard D Schellenberg

Open access · greenAbstract read
In one paragraph

Article in JAMA neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2015
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Beth A DombroskiDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia 19104, USA.
Douglas R Galasko
Ignacio F Mata
Cyrus P Zabetian
Ulla-Katrina Craig
Ralph M Garruto
Kiyomitsu Oyanagi
Gerard D Schellenberg
University of Pennsylvania · US

Funding

VIRUS-INDUCED BRAIN PATHOLOGYP50AG005131 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BREWER, JAMES B · 1985 to 2018
$55.4M
Transgenic Mouse Models of Tau PathologiesP01AG017586 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M · 2000 to 2021
$37.3M
Udall Center Director's meeting poster awardP50NS062684 · NINDS · UNIVERSITY OF WASHINGTON · PI MONTINE, THOMAS J · 2009 to 2020
$18.3M
PREVALENCE /INCIDENCE /RISK FACTORS FOR DEMENTIA ON GUAMP01AG014382 · NIA · UNIVERSITY OF WASHINGTON · PI PERL, DANIEL P · 1997 to 2006
$13.4M
Genomic Analysis of Alzheimer's Disease GenesR37AG011762 · NIA · UNIVERSITY OF WASHINGTON · PI SCHELLENBERG, GERARD DAVID · 2004 to 2013
$2.7M
Using Multiplex Families to map Genes that Modify Susceptibility and Age at OnsetR01NS065070 · NINDS · UNIVERSITY OF WASHINGTON · PI ZABETIAN, CYRUS P · 2009 to 2012
$2.0M
NIA NIH HHS AG14382NIA NIH HHS P01 AG014382NIA NIH HHS P01 AG017586NIA NIH HHS P01-AG-017586NIA NIH HHS P50 AG005131NIA NIH HHS R37 AG011762NIA NIH HHS R37 AG11762NINDS NIH HHS P50 NS062684NINDS NIH HHS R01 NS065070
6 · The paper itself

Abstract

importanceHigh-prevalence foci of amyotrophic lateral sclerosis (ALS) and parkinsonism-dementia complex (PDC) exist in Japanese on the Kii Peninsula of Japan and in the Chamorros of Guam. Clinical and neuropathologic similarities suggest that the disease in these 2 populations may be related. Recent findings showed that some of the Kii Peninsula ALS cases had pathogenic C9orf72 repeat expansions, a genotype that causes ALS in Western populations.

objectivesTo perform genotyping among Guam residents to determine if the C9orf72 expanded repeat allele contributes to ALS-PDC in this population and to evaluate LRRK2 for mutations in the same population. DESIGN AND

settingCase-control series from neurodegenerative disease research programs on Guam that screened residents for ALS, PDC, and dementia.

participantsStudy participants included 24 with ALS and 22 with PDC and 43 older control subjects with normal cognition ascertained between 1956 and 2006. All but one participant were Chamorro, the indigenous people of Guam. A single individual of white race/ethnicity with ALS was ascertained on Guam during the study. MAIN OUTCOMES AND MEASURES: Participants were screened for C9orf72 hexanucleotide repeat length. Participants with repeat numbers in great excess of 30 were considered to have pathogenic repeat expansions. LRRK2 was screened for point mutations by DNA sequencing.

resultsWe found a single individual with an expanded pathogenic hexanucleotide repeat. This individual of white race/ethnicity with ALS was living on Guam at the time of ascertainment but had been born in the United States. All Chamorro participants with ALS and PDC and control subjects had normal repeats, ranging from 2 to 17 copies. No pathogenic LRRK2 mutations were found. CONCLUSIONS AND RELEVANCE: Unlike participants with ALS from the Kii Peninsula, C9orf72 expansions do not cause ALS-PDC in Chamorros. Likewise, LRRK2 mutations do not cause Guam ALS-PDC.

Indexed as

AdultAmino Acid SequenceAmyotrophic Lateral SclerosisC9orf72 ProteinDNA Repeat ExpansionFemaleGene DosageGuamHumansLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MaleMiddle AgedMolecular Sequence DataProteinsProtein Serine-Threonine KinasesC9orf72 ProteinC9orf72 protein, humanLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanProteinsProtein Serine-Threonine Kinases

Identifiers

PMID23588498
PMCPMC3771869
OpenAlexW2064572695

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.